feed,title,long_url,short_url
SeekingAlpha,FDA grants approval to Liminal BioSciences' Ryplazim treatment,https://seekingalpha.com/news/3703449,
SeekingAlpha,DocuSign CEO: 'well less than 10% penetrated in market',https://seekingalpha.com/news/3703445,
